Mint Venture Partners

Operator of a novel bioadhesive biomaterial platform intended to develop bioadhesive tapes, pastes, and powders to bind tissues or organs. The company's tapes can be used in place of sutures to promote healing and minimize complications after surgery, thus revolutionizing the treatment of bleeding and wounds. mechanical integration of devices to the human body, enabling patients who suffered multiple traumatic injuries to get required intensive care.

Sonic Incytes Medical Corp is a medical device company based in Vancouver, Canada, focused on developing handheld ultrasound solutions for the assessment and monitoring of chronic liver diseases. Incorporated in 2012, the company aims to enhance routine liver health evaluation through non-invasive methods that provide reliable diagnostic accuracy. Its portable ultrasound devices are designed for point-of-care diagnostics and procedure guidance, enabling healthcare practitioners to improve the standard of care in quantifying conditions such as fatty liver disease. Through its innovative technology, Sonic Incytes seeks to facilitate better management of liver health for patients.

GenoTwin is a genomics platform that develops clinical tools intended to monitor and manage the emergence and spread of pathogens. It combines cutting-edge capabilities in genomics, artificial intelligence, and computational biology to address the limitations of traditional testing. The company arms medical professionals, public health officials, and researchers with powerful testing insights to diagnose, monitor, and precision-treat pathogens and pathogen-based cancers. Founded in 2020 and is headquartered in Bridgewater, MA.

Developer of health care devices designed to help people with Parkinson's improve their quality of life. The company develops a non-invasive wearable device that modulates sensory dysfunction, helping people with Parkinson's disease to improve their movement speed while living a normal life.

Senda Biosciences is pioneering the field of Intersystems Biology to create novel treatments for human disease. Intersystems Biology focuses on how molecular connections between botanical, bacterial, and human cells—coevolved over millennia—define health and disease. Senda's Intersytems Biology discovery platform, built using new techniques in machine learning and computational biology, has been able to generate novel, actionable insights into the trillions of interspecies molecular connections in the human body, and harnesses the power of this "pharmacy within us" with novel pharmacological approaches. The power of the Senda platform is illustrated by six preclinical programs in oncology, neurology, chronic disease, and metabolic disease.

Developer of biomedical sensor technology designed to improve human race health by providing accurate diagnoses. The company's technology offers a small-sized, patch-type electrocardiogram that is attached to the test subject's chest and checks in real-time, enabling physicians to manage and prevent heart disease in patients.